Table 3.

Expression levels of proteins in LoVo cells overexpressed GOLPH3 under TDH treatment.

Group	p-p70S6K/p70S6K	β-Catenin	GOLPH3
pCMV-control	1.00 ± 0.18	1.00 ± 0.11	1.00 ± 0.27
pCMV-GOLPH3	1.29 ± 0.18∗	1.63 ± 0.06∗∗	3.82 ± 0.52∗
TDH + pCMV-control	0.29 ± 0.05∗	0.24 ± 0.07∗	0.17 ± 0.12∗
TDH + pCMV-GOLPH3	1.24 ± 0.17##	1.82 ± 0.44#	3.57 ± 0.55#

Results are shown as mean ± SD. The GOLPH3 Group and Experimental Group 3 compared with the p-CMV-2 Group (^∗P < 0.05, ^∗∗P < 0.01); Experimental Group 4 compared with Experimental Group 3 (^#P < 0.05, ^##P < 0.01).